<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(1)</volume><submitter>Hsieh CC</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Upper tract urothelial carcinoma (UTUC) presents a significant recurrence risk following radical nephroureterectomy (RNU). Patients on dialysis may experience unique clinical trajectories due to uremic states and altered immune responses.&lt;h4>Objective&lt;/h4>To evaluate the impact of dialysis on intravesical recurrence and survival outcomes in patients with UTUC undergoing RNU, and to identify predictive factors influencing prognosis.&lt;h4>Methods&lt;/h4>A retrospective cohort study analyzed 402 patients with non-metastatic UTUC treated with RNU between 2001 and 2014. Patients were stratified into dialysis (&lt;i>n&lt;/i> = 66) and non-dialysis (&lt;i>n&lt;/i> = 336) groups. Survival and recurrence outcomes were assessed using Kaplan-Meier and Cox regression analyses.&lt;h4>Results&lt;/h4>Dialysis patients were predominantly female, younger, and exhibited less advanced pathological tumor stages. Dialysis was associated with higher intravesical recurrence rates (&lt;i>p&lt;/i> = 0.009), which were largely attributable to a history of bladder cancer (42.4% vs. 26.5%; &lt;i>p&lt;/i> = 0.009). After adjustment for bladder cancer history, dialysis was not an independent predictor of bladder recurrence-free survival (BRFS). Advanced pT stages (HR: 3.9, &lt;i>p&lt;/i> = 0.012) and prior bladder cancer were the primary factors influencing BRFS.&lt;h4>Conclusions&lt;/h4>Dialysis does not independently worsen surgical outcomes or BRFS in UTUC patients post-RNU when accounting for prior bladder cancer. Prognostic models should integrate these findings to enhance individualized surveillance and treatment strategies.</pubmed_abstract><journal>Renal failure</journal><pagination>2458762</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11809166</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of dialysis on intravesical recurrence and survival outcomes in upper tract urothelial cancer patients undergoing radical nephroureterectomy.</pubmed_title><pmcid>PMC11809166</pmcid><pubmed_authors>Hsieh CC</pubmed_authors><pubmed_authors>Li WM</pubmed_authors><pubmed_authors>Chien TM</pubmed_authors><pubmed_authors>Wu WJ</pubmed_authors><pubmed_authors>Li CC</pubmed_authors><pubmed_authors>Juan YS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of dialysis on intravesical recurrence and survival outcomes in upper tract urothelial cancer patients undergoing radical nephroureterectomy.</name><description>&lt;h4>Background&lt;/h4>Upper tract urothelial carcinoma (UTUC) presents a significant recurrence risk following radical nephroureterectomy (RNU). Patients on dialysis may experience unique clinical trajectories due to uremic states and altered immune responses.&lt;h4>Objective&lt;/h4>To evaluate the impact of dialysis on intravesical recurrence and survival outcomes in patients with UTUC undergoing RNU, and to identify predictive factors influencing prognosis.&lt;h4>Methods&lt;/h4>A retrospective cohort study analyzed 402 patients with non-metastatic UTUC treated with RNU between 2001 and 2014. Patients were stratified into dialysis (&lt;i>n&lt;/i> = 66) and non-dialysis (&lt;i>n&lt;/i> = 336) groups. Survival and recurrence outcomes were assessed using Kaplan-Meier and Cox regression analyses.&lt;h4>Results&lt;/h4>Dialysis patients were predominantly female, younger, and exhibited less advanced pathological tumor stages. Dialysis was associated with higher intravesical recurrence rates (&lt;i>p&lt;/i> = 0.009), which were largely attributable to a history of bladder cancer (42.4% vs. 26.5%; &lt;i>p&lt;/i> = 0.009). After adjustment for bladder cancer history, dialysis was not an independent predictor of bladder recurrence-free survival (BRFS). Advanced pT stages (HR: 3.9, &lt;i>p&lt;/i> = 0.012) and prior bladder cancer were the primary factors influencing BRFS.&lt;h4>Conclusions&lt;/h4>Dialysis does not independently worsen surgical outcomes or BRFS in UTUC patients post-RNU when accounting for prior bladder cancer. Prognostic models should integrate these findings to enhance individualized surveillance and treatment strategies.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2025-04-04T08:26:20.436Z</modification><creation>2025-04-04T08:26:20.436Z</creation></dates><accession>S-EPMC11809166</accession><cross_references><pubmed>39920881</pubmed><doi>10.1080/0886022X.2025.2458762</doi></cross_references></HashMap>